Correlation Between Royal Bank and Cipher Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Royal Bank and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Bank and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Royal Bank of and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Royal Bank and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Bank with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Bank and Cipher Pharmaceuticals.

Diversification Opportunities for Royal Bank and Cipher Pharmaceuticals

0.27

Correlation Coefficient

Royal Bank  Cipher Pharmaceuticals

Modest diversification

The 3 months correlation between Royal and Cipher is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Royal Bank of and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Royal Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Bank of are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Royal Bank i.e., Royal Bank and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Royal Bank and Cipher Pharmaceuticals

Assuming the 90 days trading horizon Royal Bank is expected to generate 3.45 times less return on investment than Cipher Pharmaceuticals. But when comparing it to its historical volatility, Royal Bank of is 11.69 times less risky than Cipher Pharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1,111  in Cipher Pharmaceuticals on April 20, 2025 and sell it today you would earn a total of  122.00  from holding Cipher Pharmaceuticals or generate 10.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Royal Bank of  vs.  Cipher Pharmaceuticals

Royal Bank

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Royal Bank of are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Royal Bank is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Cipher Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cipher Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal technical indicators, Cipher Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Royal Bank and Cipher Pharmaceuticals

The main advantage of trading using opposite Royal Bank and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Bank position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.

The idea behind Royal Bank of and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.